ResearcherUniversity of California, Los AngelesActive in the last 2 years

Yinglan Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5168-5842; OpenAlex author ID A5021418911. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Na Su · 1 shared paper, 2024 · strength 0.22
- Paper Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data. DOI 10.3389/fphar.2024.1510220 ↗
James W. Sinnett‐Smith · 1 shared paper, 2017 · strength 0.08
- Paper Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells. DOI 10.1158/1541-7786.mcr-17-0023 ↗
Hao Fang · 1 shared paper, 2017 · strength 0.08
- Paper Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells. DOI 10.1158/1541-7786.mcr-17-0023 ↗
Qinhong Xu · 1 shared paper, 2017 · strength 0.08
- Paper Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells. DOI 10.1158/1541-7786.mcr-17-0023 ↗
Enrique Rozengurt · 1 shared paper, 2017 · strength 0.08
- Paper Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells. DOI 10.1158/1541-7786.mcr-17-0023 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.